Drug test to qualitatively assess the cells expressing the CD16
Vietnam·Risk Class TTBYT Loại C·BD CD16 (NKP15) FITC·Becton, Dickinson and Company, BD Biosciences·Registered Nov 02, 2024- Analysis ID
- 2403154ĐKLH/BYT-HTTB
- Submission ID
- 000.00.04.G18-220616-0009
- Product Type
- BD CD16 (NKP15) FITC
- Product Code
- 335035
- Manufacturer
- Becton, Dickinson and Company, BD Biosciences
- Manufacturer Country
- Theo theo phụ lục
- Product Owner
- Becton, Dickinson and Company, BD Biosciences
- Authorized Representative
- VĂN PHÒNG ĐẠI DIỆN BECTON DICKINSON ASIA LIMITED TẠI THÀNH PHỐ HỒ CHÍ MINH
- Intended Use
- CD16 (NKP15) is used in in vitro diagnosis to determine the presence of CD16 antigen-expressing cells in peripheral blood, using the BD FACSLyric™ flow cytometry analyzer. Clinical Applications: Expression of the CD16 antigen in the characteristics of individuals with or suspected of having acute myeloid leukemia. CD16 (NKP15) is a qualitative test reagent intended for use only in laboratories.
- Registration Date
- Nov 02, 2024
Access comprehensive regulatory information for Drug test to qualitatively assess the cells expressing the CD16 in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403154ĐKLH/BYT-HTTB and manufactured by Becton, Dickinson and Company, BD Biosciences. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN BECTON DICKINSON ASIA LIMITED TẠI THÀNH PHỐ HỒ CHÍ MINH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.